Lymphoma:@0.809078:0.035749:0.914545:0.035749:0.914545:0.019993:0.809078:0.019993:0.008447:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
103:@0.950254:0.038184:0.981863:0.038184:0.981863:0.018587:0.950254:0.018587:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Table 2. The three clinical lymphoma groups and the approach to diagnosis:@0.084848:0.096166:0.775266:0.096166:0.775266:0.080132:0.084848:0.080132:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.007889:0.011353:0.012123:0.005195:0.005580:0.011353:0.005965:0.012123:0.012123:0.005195:0.012123:0.004426:0.004426:0.011353:0.004426:0.012123:0.012508:0.004426:0.005195:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012508:0.005195:0.012508:0.005965:0.012123:0.011353:0.012508:0.008274:0.005195:0.012508:0.011353:0.012508:0.005195:0.005580:0.011353:0.012123:0.005195:0.012508:0.012508:0.012508:0.005965:0.012123:0.012508:0.012123:0.011353:0.005195:0.005580:0.012123:0.005195:0.012508:0.004426:0.012508:0.012508:0.011353:0.012123:0.008274:0.004426:0.008467
Clinical :@0.094474:0.126918:0.168551:0.126918:0.168551:0.110884:0.094474:0.110884:0.014817:0.004426:0.004426:0.011353:0.004426:0.012123:0.012508:0.004612:0.005388
lymphoma :@0.094474:0.143084:0.199732:0.143084:0.199732:0.127050:0.094474:0.127050:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012702:0.005388
disease :@0.094474:0.159250:0.170291:0.159250:0.170291:0.143216:0.094474:0.143216:0.012508:0.004426:0.008274:0.012123:0.012508:0.008274:0.012317:0.005388
expression:@0.094474:0.175416:0.192418:0.175416:0.192418:0.159382:0.094474:0.159382:0.012123:0.010583:0.012508:0.005965:0.012123:0.008274:0.008274:0.004426:0.012123:0.011545
Cell-of-origin  Typical  :@0.227266:0.126905:0.440895:0.126905:0.440895:0.110871:0.227266:0.110871:0.014817:0.012123:0.004426:0.004426:0.007889:0.012123:0.005195:0.007889:0.012123:0.005965:0.004426:0.012508:0.004426:0.011547:0.005388:0.012929:0.007889:0.010968:0.012508:0.004426:0.012123:0.012508:0.004612:0.005009:0.857770
causing  :@0.227266:0.143071:0.310393:0.143071:0.310393:0.127037:0.227266:0.127037:0.012123:0.012508:0.011353:0.008274:0.004426:0.011353:0.012704:0.004999:0.005388
lymphoma:@0.227266:0.159237:0.327134:0.159237:0.327134:0.143203:0.227266:0.143203:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012700
demo- :@0.365465:0.143071:0.433583:0.143071:0.433583:0.127037:0.365465:0.127037:0.012508:0.012123:0.017895:0.012123:0.008082:0.005388
graphics:@0.365465:0.159237:0.445321:0.159237:0.445321:0.143203:0.365465:0.143203:0.012508:0.005965:0.012508:0.012508:0.011353:0.004426:0.012123:0.008467
Typical :@0.503664:0.126905:0.574085:0.126905:0.574085:0.110871:0.503664:0.110871:0.007889:0.010968:0.012508:0.004426:0.012123:0.012508:0.004612:0.005388
lymphoma :@0.503664:0.143071:0.608921:0.143071:0.608921:0.127037:0.503664:0.127037:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012702:0.005388
subtypes :@0.503664:0.159237:0.590832:0.159237:0.590832:0.143203:0.503664:0.143203:0.008274:0.011353:0.012508:0.005580:0.010968:0.012508:0.012123:0.008467:0.005388
encountered  and :@0.503664:0.175403:0.683815:0.175390:0.683815:0.159356:0.503664:0.159369:0.012123:0.011353:0.012123:0.012123:0.011353:0.011353:0.005580:0.012123:0.005965:0.012123:0.012702:0.005388:0.013891:0.012508:0.011353:0.012704:0.544327
in clinical :@0.503664:0.191569:0.596023:0.191569:0.596023:0.175535:0.503664:0.175535:0.004426:0.011353:0.005195:0.012123:0.004426:0.004426:0.011353:0.004426:0.012123:0.012508:0.004614:0.005388
practice:@0.503664:0.207735:0.581210:0.207735:0.581210:0.191701:0.503664:0.191701:0.012508:0.005965:0.012508:0.012123:0.005580:0.004426:0.012123:0.012315
Risk to  :@0.641862:0.126892:0.709961:0.126892:0.709961:0.110858:0.641862:0.110858:0.010968:0.004426:0.008274:0.010968:0.005195:0.005580:0.012317:0.004982:0.005388
patient if  :@0.641862:0.143058:0.731320:0.143058:0.731320:0.127024:0.641862:0.127024:0.012508:0.012508:0.005580:0.004426:0.012123:0.011353:0.005580:0.005195:0.004426:0.005384:0.004988:0.005388
undiagnosed :@0.641862:0.159224:0.768479:0.159224:0.768479:0.143190:0.641862:0.143190:0.011353:0.011353:0.012508:0.004426:0.012508:0.012508:0.011353:0.012123:0.008274:0.012123:0.012702:0.005388
untreated:@0.641862:0.191556:0.731147:0.191556:0.731147:0.175522:0.641862:0.175522:0.011353:0.011353:0.005580:0.005965:0.012123:0.012508:0.005580:0.012123:0.012700
Diagnostic :@0.786835:0.126878:0.889016:0.126878:0.889016:0.110845:0.786835:0.110845:0.013277:0.004426:0.012508:0.012508:0.011353:0.012123:0.008274:0.005580:0.004426:0.012319:0.005388
urgency:@0.786835:0.143044:0.863420:0.143044:0.863420:0.127011:0.786835:0.127011:0.011353:0.005965:0.012508:0.012123:0.011353:0.012123:0.011161
Low-grade :@0.094435:0.236389:0.200653:0.236389:0.200653:0.220170:0.094435:0.220170:0.008467:0.012315:0.015394:0.008082:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388
or indolent :@0.094435:0.252555:0.199114:0.252555:0.199114:0.236336:0.094435:0.236336:0.012315:0.006158:0.005388:0.004618:0.011545:0.012700:0.012315:0.004618:0.012315:0.011545:0.005773:0.005388
lymphoma:@0.094435:0.268721:0.195650:0.268721:0.195650:0.252502:0.094435:0.252502:0.004618:0.011161:0.018088:0.012700:0.011545:0.012315:0.018088:0.012700
Mature B-:@0.227227:0.236389:0.317257:0.236389:0.317257:0.220633:0.227227:0.220633:0.017684:0.013143:0.006523:0.011699:0.005709:0.012508:0.005330:0.011045:0.006388
cells and less  disease  :@0.227227:0.252555:0.446206:0.252542:0.446206:0.236786:0.227227:0.236799:0.012450:0.012508:0.003848:0.003848:0.007466:0.005272:0.013143:0.011738:0.013181:0.005272:0.003848:0.012508:0.007466:0.007466:0.005330:0.012854:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.669253
often ma-:@0.227227:0.268721:0.319533:0.268721:0.319533:0.252965:0.227227:0.252965:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.018049:0.013123:0.006388
ture T-cells:@0.227227:0.284887:0.323701:0.284887:0.323701:0.269132:0.227227:0.269132:0.006523:0.011699:0.005707:0.012508:0.005330:0.008197:0.006388:0.012450:0.012508:0.003848:0.003848:0.007466
Usually a :@0.365426:0.236376:0.452152:0.236376:0.452152:0.220620:0.365426:0.220620:0.012604:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330:0.013143:0.005330
of the  :@0.365426:0.268708:0.430812:0.268708:0.430812:0.252952:0.365426:0.252952:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005311:0.005330
elderly,  :@0.365426:0.284874:0.443416:0.284874:0.443416:0.269118:0.365426:0.269118:0.012508:0.003848:0.013181:0.012508:0.005792:0.003848:0.010314:0.005330:0.005330:0.005330
peak :@0.365426:0.301040:0.419189:0.301040:0.419189:0.285284:0.365426:0.285284:0.013123:0.012508:0.013143:0.009660:0.005330
incidence :@0.365426:0.317206:0.465025:0.317206:0.465025:0.301450:0.365426:0.301450:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005330
around 60 :@0.365426:0.333372:0.465487:0.333372:0.465487:0.317616:0.365426:0.317616:0.013143:0.005715:0.012604:0.011699:0.011738:0.013181:0.005330:0.010660:0.010660:0.005330
years:@0.365426:0.349538:0.414648:0.349538:0.414648:0.333782:0.365426:0.333782:0.010314:0.012508:0.013143:0.005792:0.007466
Chronic :@0.503625:0.236350:0.582686:0.236350:0.582686:0.220594:0.503625:0.220594:0.015644:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.005330
lymphocytic  indolent :@0.503625:0.252516:0.723142:0.252489:0.723142:0.236733:0.503625:0.236760:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330:0.017607:0.003848:0.011738:0.013181:0.012604:0.003848:0.012508:0.011738:0.006523:0.392393
leukaemia :@0.503625:0.268682:0.607361:0.268682:0.607361:0.252926:0.503625:0.252926:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
(CLL):@0.503625:0.284848:0.551250:0.284848:0.551250:0.269092:0.503625:0.269092:0.007100:0.015644:0.008890:0.008890:0.007100
Splenic  :@0.503625:0.317180:0.581384:0.317180:0.581384:0.301424:0.503625:0.301424:0.009583:0.013123:0.003848:0.012508:0.011738:0.003848:0.012450:0.005330:0.005330
lymphomas:@0.503625:0.333346:0.611960:0.333346:0.611960:0.317590:0.503625:0.317590:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466
Follicular :@0.503625:0.365678:0.589369:0.365678:0.589369:0.349922:0.503625:0.349922:0.009333:0.012604:0.003848:0.003848:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330
lymphoma:@0.503625:0.381844:0.604494:0.381844:0.604494:0.366088:0.503625:0.366088:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143
Not all  :@0.641824:0.236323:0.712020:0.236323:0.712020:0.220567:0.641824:0.220567:0.014239:0.012604:0.006523:0.005330:0.013143:0.003848:0.003848:0.005330:0.005330
lymphomas :@0.641824:0.268655:0.755489:0.268655:0.755489:0.252899:0.641824:0.252899:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330
need treat-:@0.641824:0.284821:0.747875:0.284821:0.747875:0.269065:0.641824:0.269065:0.011738:0.012508:0.012508:0.013181:0.005330:0.006523:0.005702:0.012508:0.013143:0.006523:0.006388
ment:@0.641824:0.300987:0.690642:0.300987:0.690642:0.285231:0.641824:0.285231:0.018049:0.012508:0.011738:0.006523
Treatment :@0.641824:0.333319:0.741479:0.333319:0.741479:0.317563:0.641824:0.317563:0.007620:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
delay  :@0.641824:0.349485:0.705478:0.349485:0.705478:0.333730:0.641824:0.333730:0.013181:0.012508:0.003848:0.013143:0.010314:0.005330:0.005330
unlikely to :@0.641824:0.365651:0.739075:0.365651:0.739075:0.349896:0.641824:0.349896:0.011699:0.011738:0.003848:0.003848:0.009660:0.012508:0.003848:0.010314:0.005330:0.006523:0.012604:0.005330
impact  :@0.641824:0.381818:0.719621:0.381818:0.719621:0.366062:0.641824:0.366062:0.003848:0.018049:0.013123:0.013143:0.012450:0.006523:0.005330:0.005330
mortality:@0.641824:0.397984:0.722469:0.397984:0.722469:0.382228:0.641824:0.382228:0.018049:0.012604:0.005792:0.006523:0.013143:0.003848:0.003848:0.006523:0.010314
Less urgent :@0.786796:0.236297:0.895010:0.236297:0.895010:0.220541:0.786796:0.220541:0.008890:0.012508:0.007466:0.007466:0.005330:0.011699:0.005805:0.012950:0.012508:0.011738:0.006523:0.005330
to diagnose :@0.786796:0.252463:0.904021:0.252463:0.904021:0.236707:0.786796:0.236707:0.006523:0.012604:0.005330:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.005330
and also :@0.786796:0.268629:0.872579:0.268629:0.872579:0.252873:0.786796:0.252873:0.013143:0.011738:0.013181:0.005330:0.013143:0.003848:0.007466:0.012604:0.005330
easier.:@0.786796:0.284795:0.845982:0.284795:0.845982:0.269039:0.786796:0.269039:0.012508:0.013143:0.007466:0.003848:0.012508:0.004383:0.005330
Disease  :@0.786796:0.300961:0.868711:0.300961:0.868711:0.285205:0.786796:0.285205:0.014316:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
often spills :@0.786796:0.317127:0.886472:0.317127:0.886472:0.301371:0.786796:0.301371:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.007466:0.013123:0.003848:0.003848:0.003848:0.007466:0.005330
into blood-:@0.786796:0.333293:0.888589:0.333293:0.888589:0.317537:0.786796:0.317537:0.003848:0.011738:0.006523:0.012604:0.005330:0.013123:0.003848:0.012604:0.012604:0.013181:0.006388
stream  :@0.786796:0.349459:0.860858:0.349459:0.860858:0.333703:0.786796:0.333703:0.007466:0.006523:0.005713:0.012508:0.013143:0.018049:0.005330:0.005330
(\leukae-:@0.786796:0.365625:0.869596:0.365625:0.869596:0.349869:0.786796:0.349869:0.007100:0.005946:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.006388
mic\):@0.786796:0.381791:0.864439:0.381791:0.864439:0.366035:0.786796:0.366035:0.018049:0.003848:0.012450:0.005946:0.005680:0.004364:0.005330:0.003848:0.007466:0.005330:0.005330
diagnosed :@0.786796:0.397957:0.892745:0.397957:0.892745:0.382201:0.786796:0.382201:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330
on BME :@0.786796:0.414123:0.860841:0.414123:0.860841:0.398367:0.786796:0.398367:0.012604:0.011738:0.005330:0.011045:0.017684:0.010314:0.005330
or easily :@0.786796:0.430289:0.866979:0.430289:0.866979:0.414533:0.786796:0.414533:0.012604:0.005792:0.005330:0.012508:0.013143:0.007466:0.003848:0.003848:0.010314:0.005330
accessible :@0.786796:0.446455:0.890936:0.446455:0.890936:0.430699:0.786796:0.430699:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.005330
mass, or  :@0.786796:0.462621:0.872637:0.462621:0.872637:0.446865:0.786796:0.446865:0.018049:0.013143:0.007466:0.007466:0.005330:0.005330:0.012604:0.005792:0.005330:0.005330
occurs in :@0.786796:0.478787:0.875504:0.478787:0.875504:0.463031:0.786796:0.463031:0.012604:0.012450:0.012450:0.011699:0.005792:0.007466:0.005330:0.003848:0.011738:0.005330
large spleen:@0.786796:0.494953:0.901579:0.494953:0.901579:0.479197:0.786796:0.479197:0.003848:0.013143:0.005813:0.012950:0.012508:0.005330:0.007466:0.013123:0.003848:0.012508:0.012508:0.011738
High-grade :@0.094397:0.529878:0.206388:0.529878:0.206388:0.513659:0.094397:0.513659:0.013085:0.004618:0.012700:0.011545:0.008082:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388
or aggres-:@0.094397:0.546044:0.191379:0.546044:0.191379:0.529825:0.094397:0.529825:0.012315:0.006158:0.005388:0.012700:0.012700:0.012700:0.006158:0.012315:0.008467:0.008082
sive lymph- :@0.094397:0.562210:0.207542:0.562210:0.207542:0.545991:0.094397:0.545991:0.008467:0.004618:0.010776:0.012315:0.005388:0.004618:0.011161:0.018088:0.012700:0.011545:0.008082:0.005388
oma:@0.094397:0.578376:0.137500:0.578376:0.137500:0.562158:0.094397:0.562158:0.012315:0.018088:0.012700
Mature B-:@0.227189:0.529865:0.317218:0.529865:0.317218:0.514109:0.227189:0.514109:0.017684:0.013143:0.006523:0.011699:0.005709:0.012508:0.005330:0.011045:0.006388
cells and less  spectrum :@0.227189:0.546031:0.458328:0.546005:0.458328:0.530249:0.227189:0.530275:0.012450:0.012508:0.003848:0.003848:0.007466:0.005272:0.013143:0.011738:0.013181:0.005272:0.003848:0.012508:0.007466:0.007466:0.005330:0.012854:0.007466:0.013123:0.012508:0.012450:0.006523:0.005792:0.011699:0.018049:0.230276
often ma-:@0.227189:0.562197:0.319494:0.562197:0.319494:0.546441:0.227189:0.546441:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.018049:0.013123:0.006388
ture T-cells,  :@0.227189:0.578363:0.339653:0.578363:0.339653:0.562607:0.227189:0.562607:0.006523:0.011699:0.005707:0.012508:0.005330:0.008197:0.006388:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330:0.005330
occurring at  age groups, :@0.227189:0.594529:0.483524:0.594503:0.483524:0.578747:0.227189:0.578773:0.012604:0.012450:0.012450:0.011699:0.005792:0.005792:0.003848:0.011738:0.012950:0.005330:0.013143:0.006523:0.005330:0.018550:0.013143:0.012950:0.012508:0.005330:0.012950:0.005703:0.012604:0.011699:0.013123:0.007466:0.005330:0.134537
an interme-:@0.227189:0.610695:0.335279:0.610695:0.335279:0.594939:0.227189:0.594939:0.013143:0.011738:0.005330:0.003848:0.011738:0.006523:0.012508:0.006317:0.018049:0.012508:0.006388
diate devel-:@0.227189:0.626861:0.340815:0.626861:0.340815:0.611105:0.227189:0.611105:0.013181:0.003848:0.013143:0.006523:0.012508:0.005330:0.013181:0.012508:0.010660:0.012508:0.003848:0.006388
opmental :@0.227189:0.643027:0.324055:0.643027:0.324055:0.627271:0.227189:0.627271:0.012604:0.013123:0.018049:0.012508:0.011738:0.006523:0.013143:0.003848:0.005330
stage:@0.227189:0.659193:0.279778:0.659193:0.279778:0.643438:0.227189:0.643438:0.007466:0.006523:0.013143:0.012950:0.012508
Wide :@0.365388:0.529839:0.418839:0.529839:0.418839:0.514083:0.365388:0.514083:0.018584:0.003848:0.013181:0.012508:0.005330
of occur-:@0.365388:0.562171:0.450728:0.562171:0.450728:0.546415:0.365388:0.546415:0.012604:0.006042:0.005330:0.012604:0.012450:0.012450:0.011699:0.005773:0.006388
rence across :@0.365388:0.578337:0.489796:0.578337:0.489796:0.562581:0.365388:0.562581:0.005713:0.012508:0.011738:0.012450:0.012508:0.005330:0.013143:0.012450:0.005703:0.012604:0.007466:0.007466:0.005330
prognosis :@0.365388:0.610669:0.458232:0.610669:0.458232:0.594913:0.365388:0.594913:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
better in the :@0.365388:0.626835:0.484710:0.626835:0.484710:0.611079:0.365388:0.611079:0.013123:0.012508:0.006523:0.006523:0.012508:0.005792:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330
young:@0.365388:0.643001:0.424693:0.643001:0.424693:0.627245:0.365388:0.627245:0.010314:0.012604:0.011699:0.011738:0.012950
Diffuse large  Undiagnosed  Early  :@0.503587:0.529812:0.840829:0.529773:0.840829:0.514017:0.503587:0.514056:0.014316:0.003848:0.006104:0.006042:0.011699:0.007466:0.012508:0.005330:0.003848:0.013143:0.005809:0.012950:0.012508:0.005330:0.017297:0.012604:0.011738:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330:0.014682:0.010314:0.013143:0.005792:0.003848:0.010314:0.005330:-0.128615
B-cell lymph-  and untreat-:@0.503587:0.545978:0.759403:0.545952:0.759403:0.530196:0.503587:0.530222:0.011045:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.006408:0.005330:0.013970:0.013143:0.011738:0.013181:0.005330:0.011699:0.011738:0.006523:0.005703:0.012508:0.013143:0.006523:-0.069663
oma:@0.503587:0.562144:0.547382:0.562144:0.547382:0.546388:0.503587:0.546388:0.012604:0.018049:0.013143
Hodgkin’s :@0.503587:0.594476:0.600260:0.594476:0.600260:0.578720:0.503587:0.578720:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330
lymphoma:@0.503587:0.610642:0.604455:0.610642:0.604455:0.594886:0.503587:0.594886:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143
Peripheral :@0.503587:0.642975:0.602608:0.642975:0.602608:0.627219:0.503587:0.627219:0.011392:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330
T-cell lymph- :@0.503587:0.659141:0.624948:0.659141:0.624948:0.643385:0.503587:0.643385:0.008197:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.006388:0.005330
omas:@0.503587:0.675307:0.554848:0.675307:0.554848:0.659551:0.503587:0.659551:0.012604:0.018049:0.013143:0.007466
ed patients :@0.641786:0.562118:0.753007:0.562118:0.753007:0.546362:0.641786:0.546362:0.012508:0.013181:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
have a risk of  increased :@0.641786:0.578284:0.884642:0.578271:0.884642:0.562515:0.641786:0.562528:0.011738:0.013143:0.010660:0.012508:0.005330:0.013143:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330:0.012604:0.006042:0.005330:0.017049:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:-0.242970
dying within :@0.641786:0.594450:0.758164:0.594450:0.758164:0.578694:0.641786:0.578694:0.013181:0.010314:0.003848:0.011738:0.012950:0.005330:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.005330
weeks to :@0.641786:0.610616:0.729704:0.610616:0.729704:0.594860:0.641786:0.594860:0.015990:0.012508:0.012508:0.009660:0.007466:0.005330:0.006523:0.012604:0.005330
months:@0.641786:0.626782:0.709904:0.626782:0.709904:0.611026:0.641786:0.611026:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466
diagnosis is :@0.786758:0.545939:0.894977:0.545939:0.894977:0.530183:0.786758:0.530183:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.003848:0.007466:0.005330
crucial, as :@0.786758:0.562105:0.886587:0.562105:0.886587:0.546349:0.786758:0.546349:0.012450:0.005792:0.011699:0.012450:0.003848:0.013143:0.003848:0.005330:0.005330:0.013143:0.007466:0.005330
stage of :@0.786758:0.594437:0.868653:0.594437:0.868653:0.578681:0.786758:0.578681:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.012604:0.006042:0.005330
disease  :@0.786758:0.610603:0.867537:0.610603:0.867537:0.594847:0.786758:0.594847:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
decreases :@0.786758:0.626769:0.889027:0.626769:0.889027:0.611013:0.786758:0.611013:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.007466:0.005330
cure rate :@0.786758:0.642935:0.877751:0.642935:0.877751:0.627179:0.786758:0.627179:0.012450:0.011699:0.005711:0.012508:0.005330:0.005792:0.013143:0.006523:0.012508:0.005330
and  :@0.786758:0.659101:0.835480:0.659101:0.835480:0.643345:0.786758:0.643345:0.013143:0.011738:0.013181:0.005330:0.005330
increases :@0.786758:0.675267:0.878927:0.675267:0.878927:0.659511:0.786758:0.659511:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.005330
mortality. :@0.786758:0.691433:0.878063:0.691433:0.878063:0.675677:0.786758:0.675677:0.018049:0.012604:0.005792:0.006523:0.013143:0.003848:0.003848:0.006523:0.010314:0.005330:0.005330
Tumour lysis :@0.786758:0.707599:0.897515:0.707599:0.897515:0.691843:0.786758:0.691843:0.007310:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330
syndrome is :@0.786758:0.723765:0.900309:0.723765:0.900309:0.708009:0.786758:0.708009:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005330:0.003848:0.007466:0.005330
possible:@0.786758:0.739931:0.860745:0.739931:0.860745:0.724175:0.786758:0.724175:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508
Very  :@0.094358:0.774856:0.148237:0.774856:0.148237:0.758637:0.094358:0.758637:0.013470:0.012315:0.006158:0.011161:0.005388:0.005388
high-grade :@0.094358:0.791022:0.204810:0.791022:0.204810:0.774803:0.094358:0.774803:0.011545:0.004618:0.012700:0.011545:0.008082:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388
or very :@0.094358:0.807188:0.164016:0.807188:0.164016:0.790969:0.094358:0.790969:0.012315:0.006158:0.005388:0.010776:0.012315:0.006158:0.011161:0.005388
aggressive :@0.094358:0.823354:0.200961:0.823354:0.200961:0.807135:0.094358:0.807135:0.012700:0.012700:0.012700:0.006158:0.012315:0.008467:0.008467:0.004618:0.010776:0.012315:0.005388
lymphoma:@0.094358:0.839520:0.195573:0.839520:0.195573:0.823301:0.094358:0.823301:0.004618:0.011161:0.018088:0.012700:0.011545:0.012315:0.018088:0.012700
Immature B-:@0.227150:0.774843:0.339945:0.774843:0.339945:0.759087:0.227150:0.759087:0.004349:0.018049:0.018049:0.013143:0.006523:0.011699:0.005711:0.012508:0.005330:0.011045:0.006388
cell or T-cell :@0.227150:0.791009:0.341431:0.791009:0.341431:0.775253:0.227150:0.775253:0.012450:0.012508:0.003848:0.003848:0.005330:0.012604:0.005792:0.005330:0.008197:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330
blastic cells :@0.227150:0.807175:0.338333:0.807175:0.338333:0.791419:0.227150:0.791419:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
or  :@0.227150:0.823341:0.256187:0.823341:0.256187:0.807585:0.227150:0.807585:0.012604:0.005792:0.005311:0.005330
Burkitt cells :@0.227150:0.839507:0.333022:0.839507:0.333022:0.823751:0.227150:0.823751:0.011045:0.011699:0.005792:0.009660:0.003848:0.006523:0.006523:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
with high :@0.227150:0.855673:0.316185:0.855673:0.316185:0.839917:0.227150:0.839917:0.015990:0.003848:0.006523:0.011738:0.005330:0.011738:0.003848:0.012950:0.011738:0.005330
turnover :@0.227150:0.871839:0.310193:0.871839:0.310193:0.856083:0.227150:0.856083:0.006523:0.011699:0.006188:0.011738:0.012604:0.010660:0.012508:0.005792:0.005330
rate:@0.227150:0.888005:0.265115:0.888005:0.265115:0.872249:0.227150:0.872249:0.005792:0.013143:0.006523:0.012508
Wide :@0.365349:0.774816:0.418801:0.774816:0.418801:0.759060:0.365349:0.759060:0.018584:0.003848:0.013181:0.012508:0.005330
spectrum :@0.365349:0.790982:0.458290:0.790982:0.458290:0.775226:0.365349:0.775226:0.007466:0.013123:0.012508:0.012450:0.006523:0.005792:0.011699:0.018049:0.005330
of occur-:@0.365349:0.807148:0.450689:0.807148:0.450689:0.791393:0.365349:0.791393:0.012604:0.006042:0.005330:0.012604:0.012450:0.012450:0.011699:0.005773:0.006388
rence across  lymphoma:@0.365349:0.823314:0.604417:0.823288:0.604417:0.807532:0.365349:0.807559:0.005713:0.012508:0.011738:0.012450:0.012508:0.005330:0.013143:0.012450:0.005703:0.012604:0.007466:0.007466:0.005330:0.013791:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:-0.311321
age groups, :@0.365349:0.839481:0.483486:0.839481:0.483486:0.823725:0.365349:0.823725:0.013143:0.012950:0.012508:0.005330:0.012950:0.005703:0.012604:0.011699:0.013123:0.007466:0.005330:0.005330
prognosis :@0.365349:0.855647:0.458194:0.855647:0.458194:0.839891:0.365349:0.839891:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
better in the  lymphoma:@0.365349:0.871813:0.604417:0.871786:0.604417:0.856030:0.365349:0.856057:0.013123:0.012508:0.006523:0.006523:0.012508:0.005792:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.018877:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:-0.381864
young:@0.365349:0.887979:0.424654:0.887979:0.424654:0.872223:0.365349:0.872223:0.010314:0.012604:0.011699:0.011738:0.012950
Acute  :@0.503548:0.774790:0.571608:0.774790:0.571608:0.759034:0.503548:0.759034:0.014239:0.012450:0.011699:0.006523:0.012508:0.005311:0.005330
lympho- :@0.503548:0.790956:0.584943:0.790956:0.584943:0.775200:0.503548:0.775200:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.006388:0.005330
blastic  :@0.503548:0.807122:0.574610:0.807122:0.574610:0.791366:0.503548:0.791366:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.005330
Burkitt  :@0.503548:0.855620:0.569299:0.855620:0.569299:0.839864:0.503548:0.839864:0.011045:0.011699:0.005792:0.009660:0.003848:0.006523:0.006523:0.005330:0.005330
Undiagnosed  Refer with-:@0.641747:0.774777:0.885048:0.774763:0.885048:0.759008:0.641747:0.759021:0.012604:0.011738:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330:0.014682:0.011680:0.012508:0.006042:0.012508:0.005792:0.005330:0.015990:0.003848:0.006523:0.011719:-0.528125
and untreat-:@0.641747:0.790943:0.759364:0.790943:0.759364:0.775187:0.641747:0.775187:0.013143:0.011738:0.013181:0.005330:0.011699:0.011738:0.006523:0.005703:0.012508:0.013143:0.006523:0.006388
ed patients :@0.641747:0.807109:0.752968:0.807109:0.752968:0.791353:0.641747:0.791353:0.012508:0.013181:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
have risk of :@0.641747:0.823275:0.751198:0.823275:0.751198:0.807519:0.641747:0.807519:0.011738:0.013143:0.010660:0.012508:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330:0.012604:0.006042:0.005330
dying within :@0.641747:0.839441:0.758125:0.839441:0.758125:0.823685:0.641747:0.823685:0.013181:0.010314:0.003848:0.011738:0.012950:0.005330:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.005330
days to :@0.641747:0.855607:0.715638:0.855607:0.715638:0.839851:0.641747:0.839851:0.013181:0.013143:0.010314:0.007466:0.005330:0.006523:0.012604:0.005330
weeks :@0.641747:0.871773:0.705208:0.871773:0.705208:0.856017:0.641747:0.856017:0.015990:0.012508:0.012508:0.009660:0.007466:0.005330
out delay :@0.786719:0.790929:0.881200:0.790929:0.881200:0.775174:0.786719:0.775174:0.012604:0.011699:0.006523:0.005330:0.013181:0.012508:0.003848:0.013143:0.010314:0.005330
(attention :@0.786719:0.807096:0.884298:0.807096:0.884298:0.791340:0.786719:0.791340:0.007100:0.013143:0.006523:0.006523:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330
to hydration :@0.786719:0.823262:0.905387:0.823262:0.905387:0.807506:0.786719:0.807506:0.006523:0.012604:0.005330:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
and renal :@0.786719:0.839428:0.882389:0.839428:0.882389:0.823672:0.786719:0.823672:0.013143:0.011738:0.013181:0.005330:0.005711:0.012508:0.011738:0.013143:0.003848:0.005330
protection) :@0.786719:0.855594:0.896786:0.855594:0.896786:0.839838:0.786719:0.839838:0.013123:0.005715:0.012604:0.006523:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007100:0.005330
High LDH :@0.786719:0.871760:0.875408:0.871760:0.875408:0.856004:0.786719:0.856004:0.013143:0.003848:0.012950:0.011738:0.005330:0.008890:0.014316:0.013143:0.005330
can point to :@0.786719:0.887926:0.907004:0.887926:0.907004:0.872170:0.786719:0.872170:0.012450:0.013143:0.011738:0.005330:0.013123:0.012604:0.003848:0.011738:0.006523:0.005330:0.006523:0.012604:0.005330
tumour lysis :@0.786719:0.904092:0.896690:0.904092:0.896690:0.888336:0.786719:0.888336:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330
syndrome:@0.786719:0.920258:0.878296:0.920258:0.878296:0.904502:0.786719:0.904502:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508